CN Patent

CN112245287A — 加压气体驱动的药剂转移和再悬浮设备和方法

Assigned to Enable Injections Inc · Expires 2021-01-22 · 5y expired

What this patent protects

描述了加压气体驱动的药剂转移和再悬浮设备和方法。该方法包括：通过将瓶插入到转移装置中来穿刺加压气体气瓶；将加压气体从穿刺的所述加压气体气瓶引入到所述瓶中；使得流体在来自所述气体的压力下从所述瓶流动；并且使得所述流体在所述加压气体的力作用下从所述瓶流动到注射装置中。

USPTO Abstract

描述了加压气体驱动的药剂转移和再悬浮设备和方法。该方法包括：通过将瓶插入到转移装置中来穿刺加压气体气瓶；将加压气体从穿刺的所述加压气体气瓶引入到所述瓶中；使得流体在来自所述气体的压力下从所述瓶流动；并且使得所述流体在所述加压气体的力作用下从所述瓶流动到注射装置中。

Drugs covered by this patent

chembl-chembl1200775 (LEUPROLIDE ACETATE)

Patent Metadata

Patent number: CN112245287A
Jurisdiction: CN
Classification: —
Expires: 2021-01-22
Drug substance claim: No
Drug product claim: No
Assignee: Enable Injections Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.